Scratching the Surface: NECTIN-4 as a Surrogate for Enfortumab Vedotin Resistance. Aggen DH, Chu CE, Rosenberg JE. Clin Cancer Res 2023;29:1377-1380.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aggen DH, Chu CE, Rosenberg JE. Scratching the Surface: NECTIN-4 as a Surrogate for Enfortumab Vedotin Resistance. Clin Cancer Res 2023;29:1377-1380.
PMID: 36749325